Homology Medicines, Inc.
USD0.93
+0.01 (+0.77%)
CEO
Paul Alloway
IPO Date
2018-03-28
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.92
Prev. Close
$0.93
Day Low
$0.90
Day High
$0.97
52W Low
$0.90
52W High
$26.64
Market Cap
$0.00B
Volume
0.40M
| 13,037 |
| $0.57 |
| 15 Feb 2024 | TZIANABOS ARTHUR | director | M-Exempt | Acquired | 14,280 | $0.00 |
| 15 Feb 2024 | TZIANABOS ARTHUR | director | M-Exempt | Disposed | 19,140 | $0.00 |
| 15 Feb 2024 | TZIANABOS ARTHUR | director | M-Exempt | Disposed | 14,280 | $0.00 |
| 8 Sept 2023 | Seymour Albert | director, officer: See Remarks | M-Exempt | Acquired | 4,620 | $0.00 |
| 8 Sept 2023 | Seymour Albert | director, officer: See Remarks | S-Sale | Disposed | 1,448 | $1.15 |
| 8 Sept 2023 | Seymour Albert | director, officer: See Remarks | M-Exempt | Disposed | 4,620 | $0.00 |
| 15 Jun 2023 | Poulton Jeffrey V. | director | A-Award | Acquired | 23,000 | $1.03 |
| 15 Jun 2023 | REICIN ALISE | director | A-Award | Acquired | 23,000 | $1.03 |